Recent 8-K filings for CABR
Highest-materiality recent filing
Caring Brands closes $3.6M PIPE with Series A Preferred and warrants; redeems 6.25M insider shares
- Issued 3,789.74 Series A Preferred shares (stated value $1,000 each) and 9,473,685 warrants at $0.40 exercise price for $3.6M gross.
- $3.075M of proceeds used to buy back 6,250,000 common shares from CEO, Chairman, and NovoDX; shares outstanding drop from 14.76M to 8.51M.
-
Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.
-
Caring Brands corrects record date in proxy statement - May 14, not May 12
Prior proxy statement (May 12, 2026) incorrectly listed May 12, 2026 as record date for annual meeting.
-
Caring Brands receives Nasdaq delisting notice for equity shortfall; stock continues trading
Stockholders' equity of $2,091,324 reported in FY2025 10-K, below Nasdaq's $2.5M minimum requirement.
-
Caring Brands reduces shareholder quorum to 33.33% and names Brian John interim CFO
Bylaw amendment cuts quorum for shareholder meetings from majority to 33.33% of outstanding shares.
-
Caring Brands closes $3.6M PIPE with Series A Preferred and warrants; redeems 6.25M insider shares
Issued 3,789.74 Series A Preferred shares (stated value $1,000 each) and 9,473,685 warrants at $0.40 exercise price for $3.6M gross.
-
Caring Brands receives two U.S. patents for hair enzyme booster technology
Two new U.S. patents granted Jan 2026 covering methods to increase sulfotransferase enzyme activity for topical hair loss treatments.
-
Caring Brands CFO Tyler Moore resigns; search for successor underway
Tyler Moore resigned as CFO on January 5, 2026, not due to any disagreement with the company.
-
Caring Brands enters exclusive global license for Emesyl nausea relief product
Licensed Emesyl OTC nausea product from Itonis; exclusive worldwide rights to manufacture, market, distribute.
-
Caring Brands raises $4M in IPO, lists on Nasdaq under 'CABR'
Sold 1,000,000 shares at $4.00; gross proceeds $4M, net ~$3.23M.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.55 · Most common event other_material